Stonehage Fleming Financial Services Holdings Ltd trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 5.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 268,363 shares of the healthcare conglomerate’s stock after selling 14,079 shares during the quarter. UnitedHealth Group accounts for about 3.8% of Stonehage Fleming Financial Services Holdings Ltd’s holdings, making the stock its 13th largest position. Stonehage Fleming Financial Services Holdings Ltd’s holdings in UnitedHealth Group were worth $135,754,000 as of its most recent filing with the SEC.
Other hedge funds have also added to or reduced their stakes in the company. Drive Wealth Management LLC boosted its stake in UnitedHealth Group by 4.6% during the fourth quarter. Drive Wealth Management LLC now owns 3,068 shares of the healthcare conglomerate’s stock valued at $1,552,000 after buying an additional 135 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its holdings in shares of UnitedHealth Group by 2.0% during the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 6,916 shares of the healthcare conglomerate’s stock worth $3,498,000 after purchasing an additional 133 shares in the last quarter. Novare Capital Management LLC raised its stake in UnitedHealth Group by 1.0% in the fourth quarter. Novare Capital Management LLC now owns 46,688 shares of the healthcare conglomerate’s stock valued at $23,618,000 after purchasing an additional 451 shares in the last quarter. Harrell Investment Partners LLC increased its holdings in shares of UnitedHealth Group by 104.5% in the 4th quarter. Harrell Investment Partners LLC now owns 13,713 shares of the healthcare conglomerate’s stock worth $6,937,000 after buying an additional 7,007 shares during the last quarter. Finally, Clarendon Private LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $1,307,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.
UnitedHealth Group Stock Up 0.5 %
Shares of UnitedHealth Group stock opened at $532.26 on Monday. The firm has a market cap of $489.83 billion, a price-to-earnings ratio of 34.34, a PEG ratio of 1.41 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a 50-day moving average of $541.04 and a 200 day moving average of $564.34.
UnitedHealth Group Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.58%. UnitedHealth Group’s dividend payout ratio is presently 54.19%.
Insider Buying and Selling
In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.33% of the stock is owned by company insiders.
Wall Street Analysts Forecast Growth
A number of equities research analysts have weighed in on the company. Stephens raised their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. TD Cowen increased their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Truist Financial decreased their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. UBS Group reduced their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $627.74.
Get Our Latest Stock Report on UNH
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
- Five stocks we like better than UnitedHealth Group
- Differences Between Momentum Investing and Long Term Investing
- MP Materials: Rare Earth Elements Powering the EV Boom
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- Short Selling – The Pros and Cons
- Bloom Energy: Powering the Future With Decentralized Energy
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.